Skip to main content

Table 3 Results of the meta-analysis

From: Prognostic value of transforming growth factor-beta in patients with colorectal cancer who undergo surgery: a meta-analysis

  Number of studies Number of patients HR (95% CI) Heterogeneity (I2, χ2, P)
Overall survival
 All 8 1119 1.68 (1.10–2.59)a 67.0%, 21.21, 0.003
  Univariate analysis 4 479 1.13 (0.85–1.51) 54.1%, 6.54, 0.088
  Multivariate analysis 4 640 2.37 (1.60–3.49) 47.3%, 5.69, 0.128
 Country     
  Asian 3 468 1.50 (0.61–3.68)a 80.4%, 10.21, 0.006
  Western 5 651 1.80 (1.33–2.45) 43.2%, 7.04, 0.134
Disease-free survival
 All 7 859 1.11 (1.03–1.19) 33.0%, 8.96, 0.176
  Univariate analysis 4 377 0.86 (0.60–1.24) 0.0%, 2.18, 0.536
  Multivariate analysis 3 482 1.12 (1.04–1.21) 59.4%, 4.92, 0.085
 Country     
  Asian 3 554 1.42 (0.61–3.31)a 71.6%, 7.04, 0.030
  Western 4 305 1.11 (1.03–1.20) 0.0%, 1.56, 0.667
  1. aThe result was based on the random effect model